S.S.S. Diagnostic & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.04 Cr
as on 24-10-2024
- Revenue 20.21%
(FY 2023)
- Profit -188.09%
(FY 2023)
- Ebitda -79.80%
(FY 2023)
- Net Worth -24.85%
(FY 2023)
- Total Assets -28.18%
(FY 2023)
About S.S.S. Diagnostic & Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.04 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kulbhushan Sood, Amit Jain, Suman Setia, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110CH2011PTC032918
- Company No.
032918
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at S.S.S. Diagnostic & Research Centre?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kulbhushan Sood  | Director | 02-May-2011 | Current |
| Amit Jain | Director | 02-May-2011 | Current |
| Suman Setia | Director | 13-Sep-2013 | Current |
| Charandeep Singh | Director | 03-May-2022 | Current |
Financial Performance of S.S.S. Diagnostic & Research Centre.
S.S.S. Diagnostic & Research Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.21% increase. The company also saw a substantial fall in profitability, with a 188.09% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S.S.S. Diagnostic & Research Centre?
In 2023, S.S.S. Diagnostic & Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanjivini Scanning Solutions Private LimitedActive 13 years 9 monthsKulbhushan Sood and Suman Setia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Nov 2016 | ₹1.04 Cr | Satisfied |
How Many Employees Work at S.S.S. Diagnostic & Research Centre?
Unlock and access historical data on people associated with S.S.S. Diagnostic & Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S.S.S. Diagnostic & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S.S.S. Diagnostic & Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
